RxDoctor Payments DataLook up a doctor →

Khoa Vo, MD

Psychiatry · Mt Pleasant, SCNPI 1225094931

Payments from drug & device makers

$21,313in general payments, 2019–2025

Across 1,201 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$3K
  • AbbVie$3K
  • Lundbeck LLC$2K
  • Axsome Therapeutics, Inc.$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Supernus Pharmaceuticals, Inc.$1K
  • plus $11K from 29 others

What the payments were for

  • Food & beverage$21,13999%
  • Education$1741%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,313 in reported general payments places this provider in the 90th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$42,658
Medicare patients
49
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HetliozTasimelteon12$264,437
AuvelityDextromethorphan Hbr/Bupropion23$32,477
CaplytaLumateperone Tosylate13$21,299
BelsomraSuvorexant26$13,837
QuviviqDaridorexant Hcl15$7,023
Loreev XrLorazepam14$5,768
Clozapine27$3,373
Lisdexamfetamine Dimesylate14$2,976
Varenicline Tartrate11$2,731
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine95$2,210
Bupropion XlBupropion Hcl59$1,167
Duloxetine Hcl43$1,013
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$776
Venlafaxine Hcl ErVenlafaxine Hcl26$729
Trazodone Hcl37$652

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Vanda Pharmaceuticals Inc.Hetlioz$1,076$264,43712 claims
Axsome Therapeutics, Inc.Auvelity$1,359$32,47723 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$939$21,29913 claims
MerckBelsomra$210$13,83726 claims
Idorsia Pharmaceuticals US IncQuviviq$385$7,02315 claims
Almatica Pharma LLCLoreev Xr, Sertraline Hcl$330$5,86731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Mt Pleasant

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →